3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
4
NETWORK
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Squamous Intraepithelial Lesions
1
Papillomavirus Infections
1
HIV Infections
1
Anus Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
Radiotherapy
87
Cyclophosphamide
84
Cisplatin
79
Doxorubicin
66
Vincristine
62
Paclitaxel
55
Etoposide
50
Carboplatin
49
Filgrastim
48
Methotrexate
41
Prednisone
40
Cytarabine
37
Granulocyte Colony-Stimulating Factor
35
Radiotherapy, Intensity-Modulated
31
Platinum
31
Docetaxel
31
Gemcitabine
30
Leucovorin
28
Dexamethasone
28
Radiotherapy, Conformal
27
Fluorouracil
27
Cetuximab
26
Taxes
24
Rituximab
23
Irinotecan
23
1,2-diaminocyclohexaneplatinum II citrate
23
Radiation
21
merphos
20
Bevacizumab
19
Temozolomide
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Has results
×
Laser Therapy
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts